Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
- PMID: 15214887
- PMCID: PMC7129386
- DOI: 10.1111/j.1469-0691.2004.00956.x
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
Abstract
Treatment of severe acute respiratory syndrome (SARS) is experimental, and the effectiveness of ribavirin-steroid therapy is unclear. Forty SARS patients with progressive disease after ribavirin treatment and 1.5 g of pulsed methylprednisolone were given either convalescent plasma (n = 19) or further pulsed methylprednisolone (n = 21) in a retrospective non-randomised study. Good clinical outcome was defined as discharge by day 22 following the onset of symptoms. Convalescent plasma was obtained from recovered patients after informed consent. Patients in the plasma group had a shorter hospital stay (p 0.001) and lower mortality (p 0.049) than the comparator group. No immediate adverse effects were observed following plasma infusion.
Similar articles
-
High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome.Am J Respir Crit Care Med. 2003 Dec 15;168(12):1449-56. doi: 10.1164/rccm.200306-766OC. Epub 2003 Aug 28. Am J Respir Crit Care Med. 2003. PMID: 12947028
-
Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.Respirology. 2004 Jun;9(2):173-83. doi: 10.1111/j.1440-1843.2004.00588.x. Respirology. 2004. PMID: 15182266 Free PMC article.
-
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 6;21(1):828. doi: 10.1186/s13063-020-04735-y. Trials. 2020. PMID: 33023671 Free PMC article.
-
[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].Antibiot Khimioter. 2011;56(7-8):42-6. Antibiot Khimioter. 2011. PMID: 22359870 Review. Russian.
-
SARS: pharmacotherapy.Respirology. 2003 Nov;8 Suppl:S25-30. doi: 10.1046/j.1440-1843.2003.00525.x. Respirology. 2003. PMID: 15018130 Review.
Cited by
-
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.Microorganisms. 2021 Apr 11;9(4):806. doi: 10.3390/microorganisms9040806. Microorganisms. 2021. PMID: 33920489 Free PMC article.
-
Convalescent Plasma Therapy for COVID-19: State of the Art.Clin Microbiol Rev. 2020 Aug 12;33(4):e00072-20. doi: 10.1128/CMR.00072-20. Print 2020 Sep 16. Clin Microbiol Rev. 2020. PMID: 32792417 Free PMC article. Review.
-
Convalescent Blood Products in COVID-19: A Narrative Review.Ther Adv Infect Dis. 2020 Sep 22;7:2049936120960646. doi: 10.1177/2049936120960646. eCollection 2020 Jan-Dec. Ther Adv Infect Dis. 2020. PMID: 33014364 Free PMC article. Review.
-
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial.Life (Basel). 2022 Oct 9;12(10):1565. doi: 10.3390/life12101565. Life (Basel). 2022. PMID: 36295001 Free PMC article.
-
Transfusion Service Response to the COVID-19 Pandemic.Am J Clin Pathol. 2020 Aug 5;154(3):280-285. doi: 10.1093/ajcp/aqaa111. Am J Clin Pathol. 2020. PMID: 32584950 Free PMC article. No abstract available.
References
-
- Lee N, Hui DS, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986–1994. - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith CS et al. A novel coronavirus associated severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953–1966. - PubMed
-
- Drosten C, Gunther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967–1976. - PubMed
-
- Centers for Disease Control and Prevention. Update: severe acute respiratory syndrome. MMWR 2003; 52: 388–390. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous